Initial assessment of the role of CXC chemokine receptor 4 after polytrauma Journal Article

Authors: Bach, H. H., 4th; Saini, V.; Baker, T. A.; Tripathi, A; Gamelli, R. L.; Majetschak, M
Article Title: Initial assessment of the role of CXC chemokine receptor 4 after polytrauma
Abstract: CXC chemokine receptor (CXCR)-4 agonists have been shown to attenuate inflammation and organ injury in various disease models, including trauma/hemorrhage. The pathophysiological role of CXCR4 during the early response to tissue injury, however, remains unknown. Therefore, we investigated the effects of AMD3100, a drug that antagonizes binding of stromal cell-derived factor (SDF)-1alpha and ubiquitin to CXCR4 during the initial response to polytrauma in pigs. Fifteen minutes before polytrauma (femur fractures/lung contusion; control: sham), 350 nmol/kg AMD3100, equimolar AMD3100 and ubiquitin (350 nmol/kg each) or vehicle were administered intravenously. After a 60-min shock period, fluid resuscitation was performed for 360 min. Ubiquitin binding to peripheral blood mononuclear cells was significantly reduced after intravenous AMD3100. SDF-1alpha plasma levels increased transiently >10-fold with AMD3100 in all animals. In injured animals, AMD3100 increased fluid requirements to maintain hemodynamics and enhanced increases in peripheral blood granulocytes, lymphocytes and monocytes, compared with its effects in uninjured animals. Cytokine release from leukocytes in response to Toll-like receptor (TLR)-2 and TLR-4 activation was increased after in vitro AMD3100 treatment of normal whole blood and after in vivo AMD3100 administration in animals subjected to polytrauma. Coadministration of AMD3100/ubiquitin reduced lactate levels, prevented AMD3100-induced increases in fluid requirements and sensitization of the tumor necrosis factor (TNF)-alpha and interleukin (IL)-6 release upon TLR-2/4 activation, but did not attenuate increases in leukocyte counts and SDF-1alpha plasma levels. Our findings suggest that CXCR4 controls leukocyte mobilization after trauma, regulates leukocyte reactivity toward inflammatory stimuli and mediates protective effects during the early phase of trauma-induced inflammation.
Journal Title: Molecular medicine
Volume: 18
ISSN: 1528-3658; 1076-1551
Publisher: Unknown  
Journal Place: United States
Date Published: 2012
Start Page: 1056
End Page: 1066
Language: eng
Notes: LR: 20130219; GR: GM008750/GM/NIGMS NIH HHS/United States; JID: 9501023; 0 (Heterocyclic Compounds); 0 (Interleukin-6); 0 (Lipopolysaccharides); 0 (Receptors, CXCR4); 0 (Receptors, Cell Surface); 0 (Teichoic Acids); 0 (Tumor Necrosis Factor-alpha); 0 (Ubiquitin); 155148-31-5 (JM 3100); 56411-57-5 (lipoteichoic acid); OID: NLM: PMC3474431; 2011/12/18 [received]; 2012/05/17 [accepted]; 2012/05/17 [aheadofprint]; epublish